Medical & Surgical Retina

2014 Fourth Module

3 March – 7 March 2014, Tel Aviv/Israel (Preliminary Programme)

Scientific coordinators: Itay Chowers, Israel; Anat Loewenstein, Israel; Joseph Moisseiev, Israel

 
MONDAY, 3 MARCH 2014
  Diabetic Retinopathy  
09:00 DME
Current classification of DME; Laser, including subthreshold;
Anti-VEGF treatments: Bevacizumab, Ranibizumab, Aflibercept
Neil Bressler, USA
09:45 Steroidal treatments, Illuvien, Ozurdex Michaella Goldstein, Israel
10:00 PDR
Anti-VEGF therapy for PDR
Neil Bressler, USA
10:30 Surgical treatment for PDR Eddie Averbukh, Israel
11:00 COFFEE BREAK  
11:30 Other issues in Diabetic Retinopathy
Slow release devices- current and novel
Albert Augustin, Germany
11:45 Release of VMT Albert Augustin, Germany
12:00 Panel with case presentations
Moderator: Neil Bressler, USA
Panelists: Albert Augustin, Germany; Itay Chowers, Israel; Eddie Averbukh, Israel; Michaella Goldstein, Israel; Ayala Pollack, Israel
 
13:00 LUNCH  
14:00 Pipeline Showcase  
15:15 – 18:45 Wet-Lab
Retinal Moderators: Adiel Barak, Israel; Amir Alhalel, Israel; Gabi Katz, Israel; Rita Ehrlich, Israel; Yoreh Barak, Israel; Orit Vidne, Israel; Shula Schwartz, Israel
 
     
TUESDAY, 4 MARCH 2014
  AMD  
09.00 Non-neovascular AMD
Epidemiology, genetics, prevention, AREDS II, monitoring, early detection, new treatment modalities
Itay Chowers, Israel
10:00 Neovascular AMD
Bevacizumab, Ranibizumab, Aflibercept; Fixed regimen, PRN, treat and extend;
New treatments (Fovista, brachytherapy)
Francesco Bandello, Italy
10:45 Long term safety Maurizio Battaglia Parodi, Italy
11:00 COFFEE BREAK  
11:30 Specific variants – PCV, RAP; Other lesions mimicking CNV; Long-term safety Maurizio Battaglia Parodi, Italy
12:00 Panel with case presentations
Moderator: Michaela Goldstein, Israel
Panelists: Francesco Bandello, Italy; Maurizio Battaglia Parodi, Italy;
Itay Chowers, Israel; Anat Loewenstein, Israel; Irit Rosenblatt, Israel
 
13:00 LUNCH  
14:00 – 17:30 Wet-Lab
Retinal Moderators: Adiel Barak, Israel; Amir Alhalel, Israel; Gabi Katz, Israel; Rita Ehrlich, Israel; Yoreh Barak, Israel; Orit Vidne, Israel; Shula Schwartz, Israel
 
     
WEDNESDAY, 5 MARCH 2014
  Retinal Vein Occlusion  
09:00 CRVO Treatment options
Bevacizumab, Ranibizumab, Aflibercept, Illuvien, Ozurdex
Dov Weinberger, Israel
10:00 BRVO Treatment options
Bevacizumab, Ranibizumab, Aflibercept, Illuvien, Ozurdex
Ruth Siegel, Israel
11:00 COFFEE BREAK  
11:30 Surgical options in RVO Joseph Ferencz, Israel
12:00 Panel with case presentations
Moderator: Ruth Siegel, Israel
Panelists: Anat Loewenstein, Israel; Joseph Moisseiev, Israel; Ayala Pollack, Israel; Dov Weinberger, Israel
 
13:00 LUNCH  
14:00 – 17:30 OCT – Imaging Course
Technology, AMD, Diabetes, Vein occlusion, Vitreomacular interface
Pseudophakic CME, Choroid – EDI, En face OCT, OCT of anterior segment
Chair:
Gabriel Coscas, France
Moderators:
Gabriel Coscas, France
Dafna Goldenberg, Israel
Iris Moroz, Israel

   
THURSDAY, 6 MARCH 2014
  Surgical Retina  
09:00 Pars Plana Vitrectomy (PPV)
Evolution of PPV techniques; Small gauge sutureless PPV – advantages & disadvantages
Joseph Moisseiev, Israel
09:45 Primary Rhegmatogenous Retinal Detachment (PRRD)
Current review of results in PRRD management– pneumatic retinopexy, scleral buckle and vitrectomy; Small-gauge vitrectomy for PRRD
Stanislao Rizzo, Italy
10:30 COFFEE BREAK  
11:00 Use of silicone oil and other tamponades with 25G PPV Dov Weinberger, Israel
11:30 Vitreoretinal Interface
Results of MIVI (ocriplasmin) – from the surgeons perspective
Stanislao Rizzo, Italy
12:00 Panel with case presentations: Challenging cases with mini-invasive vitrectomy
Moderator: Joseph Moisseiev, Israel
Panelists: Itay Chowers, Israel; Dov Weinberger, Israel; Adiel Barak, Israel; Orit Vidne, Israel
 
13:00 LUNCH  
14:00 – 15:00 Long-term management of AMD Michaella Goldstein, Israel
 
FRIDAY, 7 MARCH 2014
08:30 Live Surgery
Moderator: Eddie Averbukh, Israel
Dov Weinberger, Israel; Joseph Moisseiev, Israel; Adiel Barak, Israel
 
12:30 – 13:00 Certificates and farewell